We are live on ! Find out more
State of Wisconsin Investment Board

State of Wisconsin Investment Board Portfolio holdings

AUM $43.7B
1-Year Est. Return 27.76%
This Fund
S&P 500
This Quarter Est. Return
+8.71%
1 Year Est. Return
+27.76%
3 Year Est. Return
+95.56%
5 Year Est. Return
+123.77%
10 Year Est. Return
+486.44%
AUM
$48.3B
AUM Growth
+$1.43B
Cap. Flow
-$2B
Cap. Flow %
-4.15%
Top 10 Hldgs %
18.68%
Holding
2,220
New
201
Increased
548
Reduced
910
Closed
160

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$54.5M
2
META icon
Meta Platforms (Facebook)
META
+$49.7M
3
AZN icon
AstraZeneca
AZN
+$43.2M
4
BIIB icon
Biogen
BIIB
+$42.5M
5
ACN icon
Accenture
ACN
+$38.3M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$115M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$106M
3
JNK icon
State Street SPDR Bloomberg High Yield Bond ETF
JNK
+$92.5M
4
MSFT icon
Microsoft
MSFT
+$76.6M
5
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$73.2M

Sector Composition

Rank Sector Weight
1 Technology 22.49%
2 Financials 14.31%
3 Healthcare 13.25%
4 Consumer Discretionary 11.35%
5 Communication Services 10.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GTHX
1451
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$1.01M ﹤0.01%
45,900
– –
FLO icon
1452
Flowers Foods
FLO
$1.6B
$1M ﹤0.01%
41,415
-2,347
-5% -$57K
TVTX icon
1453
Travere Therapeutics
TVTX
$5.79B
$1M ﹤0.01%
68,600
– –
EPZM
1454
DELISTED
Epizyme, Inc
EPZM
$997K ﹤0.01%
120,000
– –
RXRX icon
1455
Recursion Pharmaceuticals
RXRX
$1.78B
$996K ﹤0.01%
+27,300
New +$808K
ACRS icon
1456
Aclaris Therapeutics
ACRS
$863M
$989K ﹤0.01%
+56,300
New +$1.28M
KPTI icon
1457
Karyopharm Therapeutics
KPTI
$45.1M
$985K ﹤0.01%
6,360
– –
NNN icon
1458
NNN REIT
NNN
$8.87B
$983K ﹤0.01%
20,959
-1,085
-5% -$50.8K
AGCO icon
1459
AGCO
AGCO
$6.96B
$972K ﹤0.01%
7,452
-121,066
-94% -$17M
STTK icon
1460
Shattuck Labs
STTK
$735M
$972K ﹤0.01%
+33,528
New +$980K
RNAM
1461
DELISTED
Avidity Biosciences
RNAM
$969K ﹤0.01%
39,200
+15,600
+66% +$363K
VSTM icon
1462
Verastem
VSTM
$604M
$965K ﹤0.01%
19,750
– –
INBX
1463
DELISTED
Inhibrx, Inc. Common Stock
INBX
$964K ﹤0.01%
+35,014
New +$729K
BDN
1464
Brandywine Realty Trust
BDN
$542M
$957K ﹤0.01%
69,775
-30,009
-30% -$414K
QCRH icon
1465
QCR Holdings
QCRH
$1.75B
$957K ﹤0.01%
19,900
– –
ATOS icon
1466
Atossa Therapeutics
ATOS
$25.5M
$956K ﹤0.01%
+10,087
New +$534K
DCI icon
1467
Donaldson
DCI
$11.1B
$956K ﹤0.01%
15,050
-1,052
-7% -$65K
TBPH icon
1468
Theravance Biopharma
TBPH
$878M
$953K ﹤0.01%
65,600
– –
RYTM icon
1469
Rhythm Pharmaceuticals
RYTM
$7.99B
$948K ﹤0.01%
48,400
– –
CBSH icon
1470
Commerce Bancshares
CBSH
$8.61B
$947K ﹤0.01%
16,213
-880
-5% -$53K
UTHR icon
1471
United Therapeutics
UTHR
$21.5B
$946K ﹤0.01%
5,271
-233
-4% -$44.4K
ITT icon
1472
ITT
ITT
$19.4B
$943K ﹤0.01%
10,291
-671
-6% -$62.5K
SMG icon
1473
ScottsMiracle-Gro
SMG
$3.59B
$941K ﹤0.01%
4,903
-236
-5% -$52.1K
JBGS
1474
JBG SMITH
JBGS
$692M
$939K ﹤0.01%
29,809
+14,362
+93% +$468K
ALK icon
1475
Alaska Air
ALK
$5.3B
$933K ﹤0.01%
15,465
-20,551
-57% -$1.39M
57 58
59
60 61

Similar funds

Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
PEAK6
PEAK6 Chicago, Illinois $42.6B AUM 66.24% 1-Year Est. Return
TCI Fund Management
TCI Fund Management London, United Kingdom $45.2B AUM 12.74% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.47% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

State of Wisconsin Investment Board's Q2 2021 Portfolio in Review

As of Q2 2021, State of Wisconsin Investment Board held 2,220 positions worth $48.3B, up 3.1% from $46.9B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

State of Wisconsin Investment Board withdrew a net $2B in Q2 2021, closing 160 positions and reducing 910 holdings. Its most notable exit was State Street SPDR Bloomberg High Yield Bond ETF, an estimated $92.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.

Against the trend, State of Wisconsin Investment Board opened a new position in AstraZeneca worth $47.2M.

  • State of Wisconsin Investment Board's largest Q2 2021 buy was AstraZeneca: 394,075 shares worth $47.2M.
  • State of Wisconsin Investment Board added most to Alphabet (Google) Class A in Q2 2021, an estimated $54.5M increase.
  • State of Wisconsin Investment Board's biggest Q2 2021 reduction was Johnson & Johnson, cutting an estimated $115M.
  • State of Wisconsin Investment Board fully exited State Street SPDR Bloomberg High Yield Bond ETF in Q2 2021, selling an estimated $92.5M.
  • State of Wisconsin Investment Board's ten largest holdings make up 19% of its $48.3B portfolio in Q2 2021.
  • State of Wisconsin Investment Board opened 201 new positions and closed 160 in Q2 2021.
  • State of Wisconsin Investment Board's portfolio value rose 3.1% quarter-over-quarter to $48.3B.

Based on State of Wisconsin Investment Board's 13F filing for Q2 2021, filed 12 Aug 2021.